I agree that this site is using cookies. You can find further informations here.
X
Shamblaw, David
19  results:
Search for persons X
?
1

Atherosclerotic Cardiovascular Disease Risk Profile of Teno..:

Huhn, Gregory D ; Shamblaw, David J ; Baril, Jean-Guy...
Open Forum Infectious Diseases.  7 (2019)  1 - p. , 2019
Link: https://doi.org/10.1093/..
 
?
2

Efficacy and Safety of Tenofovir Alafenamide vs. Tenofovir ..:

Flamm, Jason A ; Vanig, Thanes ; Gathe, Joseph...
Open Forum Infectious Diseases.  4 (2017)  suppl_1 - p. S427-S428 , 2017
Link: https://doi.org/10.1093/..
 
?
3

1567Simplification to elvitegravir/cobicistat/emtricitabine..:

Cunningham, Douglas ; Shamblaw, David ; Zurawski, Christine...
Open Forum Infectious Diseases.  1 (2014)  suppl_1 - p. S417-S417 , 2014
Link: https://doi.org/10.1093/..
 
?
4

P38: Simplification of PI+RTV+FTC/TDF to E/C/F/TDF maintain..:

David, Shamblaw ; Doug, Cunningham ; Jose, Arribas...
Journal of the International AIDS Society.  17 (2014)  2(Suppl 1) - p. , 2014
Link: https://doi.org/10.7448/..
 
?
5

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543.  , 2019
Link: https://amu.hal.science/..
 
?
6

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543.  , 2019
Link: https://amu.hal.science/..
 
?
7

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543.  , 2019
Link: https://hal-amu.archives..
 
?
8

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543.  , 2019
Link: https://amu.hal.science/..
 
?
9

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543.  , 2019
Link: https://amu.hal.science/..
 
?
10

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543.  , 2019
Link: https://amu.hal.science/..
 
?
11

Efficacy and Safety of Tenofovir Alafenamide vs. Tenofovir ..:

Flamm, Jason A ; Vanig, Thanes ; Gathe, Joseph...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630907/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
12

1567Simplification to elvitegravir/cobicistat/emtricitabine..:

Cunningham, Douglas ; Shamblaw, David ; Zurawski, Christine...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782065/.  , 2014
Link: http://www.ncbi.nlm.nih...
 
?
13

Family physicians in Quebec:

Shamblaw, David
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1485682.  , 1993
Link: http://www.ncbi.nlm.nih...
 
?
14

Reducing the Stigma of Depression Among Asian Students: A S..:

Botha, Francois B. ; Shamblaw, Amanda L. ; Dozois, David J. A.
Journal of Cross-Cultural Psychology.  48 (2016)  1 - p. 113-131 , 2016
Link: https://doi.org/10.1177/..
 
?
15

Accounting for Differences in Depression Stigma Between Can..:

Shamblaw, Amanda L. ; Botha, Francois B. ; Dozois, David J. A.
Journal of Cross-Cultural Psychology.  46 (2015)  4 - p. 597-611 , 2015
Link: https://doi.org/10.1177/..
 
1-15